WARIAM WILLIAM: Open Payments
NPI 1396868964 · RIALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 7 payments from 6 companies in 2025. Trend: 2023 $50 · 2024 $0 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Lilly USA, LLC | 1 | $33 |
| Amgen Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| PROTEGA PHARMACEUTIALS INC | 1 | $20 |
Products named: Kerendia, MOUNJARO, KRYSTEXXA, CAPLYTA, TRELEGY ELLIPTA, ROXYBOND.
Industry payments across CA — which companies pay providers there.
